Trojan Horse Inhibitor

A molecule introduced by affinity labelling into the active site of an enzyme or other protein, in order to delineate the ‘business end’ of a molecule of interest, given that a 'Trojan horse'-type molecular mimic prevents a target protein from performing its usual function